To help provide relief without the risk of abuse and overdoses, one pharmaceutical company is revealing its new pill designed to not trigger those dangers.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment

Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but it's expensive.